Details of the Drug Metabolite (DM)
| General Information of Drug Metabolite (DM) (ID: DM019634) | ||||||
|---|---|---|---|---|---|---|
| DM Name |
LIK-066 M17,27
|
|||||
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DME(s) Producing This DM through Metabolism | ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Full List of Drug(s) That Produce This DM By Metabolism | ||||||
|---|---|---|---|---|---|---|
| LIK-066 | DR3265 | Phase 2 | Heart failure | |||
| References | ||||||
|---|---|---|---|---|---|---|
| 1 | Pharmacokinetics, metabolism, and excretion of licogliflozin, a dual inhibitor of SGLT1/2, in rats, dogs, and humans | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.